Article
A polygenic score associated with fracture risk in breast cancer patients treated with aromatase inhibitors - npj Breast Cancer
Rating:
0.0
Views:
48
Likes:
1
Library:
1
Identifying women at high risk of osteoporotic fracture from aromatase inhibitor (AI) therapy for breast cancer is largely based on known risk factors for healthy postmenopausal women, which might not accurately reflect the risk in breast cancer patients post-AI therapy.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value